CloudLIMS Offers Free LIMS Globally to SARS-CoV-2 & COVID-19 Research, Testing Laboratories, and Biobanks

HTML marquee Tag Thank you for your overwhelming response to the offer! We have now stopped taking applications.

CloudLIMS recognizes the threat to global health the COVID-19 pandemic brings. To do our part, we are making our flagship in the cloud LIMS (Laboratory Information Management System), CloudLIMS Enterprise, free of charge to any research facility, biobank or diagnostics laboratory doing SARS-CoV-2 or COVID-19 research or testing, be it any part of the world.

Message from Arun Apte, CEO,


Terms of the Offer

This offer is applicable for SARS-CoV-2 or COVID-19 research, testing laboratories, and biobanks for a period of 1 year for 3 users. This offer not only includes all features and modules present in CloudLIMS Enterprise but also our entire suite of complementary services, unlimited technical support, instrument integration, product upgrades, automatic backups, legacy data migration, and secure data access. The prevailing price of CloudLIMS Enterprise is $350/user/month. You can save $12,600 if you make use of the offer now*. This offer is on a first-come-first-serve basis and is limited to the first 30 laboratories performing COVID-19 research or diagnostics who complete the on-boarding process. Please feel free to share this page with anyone doing SARS-CoV-2 or COVID-19 research.

*At the end of the first year, you may continue to use CloudLIMS Enterprise. If more than 3 users are required, you can subscribe to additional users anytime at the current pricing. The charges for the second year subscription will be calculated based on the pricing prevalent on the day the order is placed. This offer is only for new organizations that do not already have an existing contract in place with CloudLIMS.

Notice: By applying to the offer and being provided CloudLIMS Enterprise, CloudLIMS has the rights to use the institute name and logo on their website and on any publicly available materials.

© 2022 All Rights Reserved.